ISSN: 0924-8579
Journal Home
Journal Guideline
International Journal of Antimicrobial Agents Q1 Unclaimed
International Journal of Antimicrobial Agents is a journal indexed in SJR in Medicine (miscellaneous) and Infectious Diseases with an H index of 154. It has an SJR impact factor of 1,072 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,072.
International Journal of Antimicrobial Agents focuses its scope in these topics and keywords: activity, isolates, factors, clinical, infection, care, klebsiella, falciparum, antibiotic, pneumoniae, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,072
SJR Impact factor154
H Index254
Total Docs (Last Year)925
Total Docs (3 years)9032
Total Refs4304
Total Cites (3 years)816
Citable Docs (3 years)2.49
Cites/Doc (2 years)35.56
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
Management of urinary tract infections in the nursing home elderly: a proposed algorithmic approach
View moreRapid detection of methicillin resistance in staphylococci using a slide latex agglutination kit
View moreThe role of the hospital nursing staff in home health-care services
View moreA multi-centre study of nosocomial methicillin-resistant Staphylococcus aureus in Greece
View morePopulation pharmacokinetics of tobramycin in hospitalized patients receiving once-daily dosing regimen
View moreRifampicin sub-inhibitory concentrations reduce the expression of haemolysin in Aeromonas spp.
View moreStreptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates
View moreWhen to do culture in urinary tract infections
View moreBroad-spectrum beta-lactam antibiotics with beta-lactamase inhibitors
View morePrevention and management of mucositis in patients with cancer
View moreCriteria used when initiating antifungal therapy against Candida spp. in the intensive care unit
View moreModification of acquired immunity in BALB/c mice by aztreonam
View moreAntimicrobial resistance of Streptococcus pneumoniae, Haemophilius influenzae and Moraxella catarrhalis isolated in Hawaii
View moreSelective toxicity, side effects and resistance
View moreEU conference 'The Microbial Threat'
View moreHepatosplenic candidiasis in non-neutropenic patients: a case report and literature survey
View moreOutpatient parenteral antibiotic therapy
View moreUrinary tract infections in HIV disease
View moreComparative pharmacoeconomic study of vancomycin and teicoplanin in intensive care patients
View moreInfluence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology
View moreAzithromycin: the first of the tissue-selective azalides
View moreTeicoplanin vs. vancomycin for the treatment of serious infections: a randomised trial
View moreEditorial
View moreHPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations
View more
Comments